Subscribe to news

Press Releases

19.11.2014
OJSC HSCI, one of Russia’s leading biotech companies, announced its unaudited unconsolidated results for the first nine months of 2014 in accordance with the Russian Accounting Standards (RAS)
10.11.2014
OJSC HSCI, announced Moscow Arbitration Court decision on the Company’s law suit against “Russian Reporter” magazine and its founder - CJSC Expert Media Holding.
04.09.2014
OJSC HSCI, announced its unaudited consolidated interim results for the first half of 2014 (6 months ended June 30, 2014) under International Financial Reporting Standards (IFRS)
18.08.2014
OJSC HSCI, announced its unaudited unconsolidated results for the first half of 2014 in accordance with the Russian Accounting Standards (RAS)
10.07.2014
OJSC HSCI, today announced that its novel gene-therapy drug for the treatment of Peripheral Arterial Disease (PAD) and its USA development plan has received support from the Business Innovation Network of Montgomery County, Maryland, USA (www.mcinnovationnetwork.com).
20.06.2014
OJSC HSCI, today announced the results of the Annual General Shareholders’ Meeting (AGM) held on June 17, 2014 in Moscow.
26.05.2014
OJSC HSCI, announced its unaudited unconsolidated results for the first quarter of 2014 in accordance with the Russian Accounting Standards (RAS)
21.05.2014
The Human Stem Cells Institute (“HSCI”, MOEX: ISKJ), one of Russia’s leading biotech companies, today announced the decision of the Company’s Board of Directors to recommend the following annual dividends for 2013 to the Annual General Shareholder’s Meeting
06.05.2014
The Human Stem Cells Institute, today announced its audited consolidated results for the full year ended December 31, 2013 in accordance with International Financial Reporting Standards (IFRS):
28.04.2014
The Human Stem Cells Institute, today announced the decision of the Company’s Board of Directors on convocation of the Annual General Shareholders’ Meeting upon the results of 2013.